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or	genetic	 trade-	offs	when	allocating	 resources	 to	 competing	 life-	history	demands,	
such	as	growth,	survival,	and	reproduction.	These	trade-	offs	are	increasingly	consid-
ered	to	be	crucial	to	further	our	understanding	of	cancer.	First,	evidences	suggest	that	
neoplastic	 cells,	 as	 any	 living	 entities	 subject	 to	 natural	 selection,	 are	 governed	by	






evolutionary	 history,	 may	 suggest	 new	 guidelines	 for	 preventive	 and	 therapeutic	
strategies.
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1  | INTRODUCTION
Although	 medical	 and	 evolutionary	 sciences	 have	 traditionally	 de-
veloped	 in	 relative	 isolation	 (Williams	 &	 Nesse,	 1991),	 it	 is	 widely	
acknowledged	 that	 cancer	 is	 a	process	 that	 is	 shaped	by	Darwinian	
evolution	 (Aktipis	 &	Nesse,	 2013;	Thomas	 et	al.	 2013).	 Specifically,	





per se,	 to	 possible	ways	 to	 control	 its	 progression,	 and	how	 to	pre-
vent	therapeutic	failures	(Aktipis	&	Nesse,	2013;	Rozhok	&	DeGregori,	




Central	 to	 evolutionary	 theory	 is	 the	 assumption	 that	 living	
organisms	 are,	 at	 some	 level,	 resource-	limited	 and	 thus	must	 face	
trade-	offs	 among	 competing	 energy	 demands	 and	 life-	history	
traits,	such	as	development,	survival,	and	reproduction	(Roff,	1993;	
Stearns,	 1992).	 Life-	history	 theory	 proposes	 that	 these	 trade-	offs	
help	 to	 determine	 the	 evolution	 of	 phenotypes	 and	 could	 explain	
the	diversity	of	life-	history	patterns	found	in	biological	populations	
(Hawkins,	2004).	This	concept	has	 led	to	the	 idea	that	mammalian	
populations	 can	 be	 placed	 along	 a	 fast–slow	 continuum	 and	 has	
been	confirmed	by	 some	empirical	 evidence	 (see	Oli,	 2004	 for	 re-
view).	Species	selected	to	mature	early	have	high	reproductive	rates	






evolutionary	 thinking	 is	 their	 direct	 link	with	 processes	 limiting	 the	
adaptive	potential	of	organisms.	Trade-	offs	lead	to	antagonistic	rela-
tionships	between	phenotypic	traits	and	are	thought	to	be	determined	























2  | LIFE-HISTORY TRADE-OFFS AT THE 
MALIGNANT CELL LEVEL
Cells	become	malignant	by	acquiring	genetic	mutations	that	 lead	to	
increased	 survival	 and	 reproduction.	However,	 cancer	 cells	 are	 not	
Darwinian	demons	able	to	maximize	all	fitness	components	simulta-















(Aktipis	et	al.,	2013).	Selection	 for	different	 life-	history	strategies	 in	
malignant	cells	could	also	fluctuate	over	time	because	tumorigenesis	
and/or	 therapies	will	 generate	 distinct	 selective	 landscapes.	Aktipis	
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et	al.	 (2013)	hypothesized	that	 these	trade-	offs	may	only	happen	 in	
later	 stages	of	 tumorigenesis,	 favoring	extreme	phenotypes	such	as	
rapidly	proliferating	cells	with	poor	survival	abilities	or	apparently	dor-
mant	cells	that	can	survive	extremely	well.
2.2 | Dispersal and cell plasticity
Many	 animals	 disperse	 to	 reduce	 intraspecific	 competition	 (Fahrig,	
2007).	Models	 in	evolutionary	ecology	have	also	shown	that	organ-
isms	should	move	only	when	the	costs	of	“staying	at	home”	outweigh	
the	 potential	 costs	 of	 leaving	 the	 natal	 habitat	 (North,	 Cornell,	 &	
Ovaskainen,	2011).	Cancer	cells	within	organs	face	the	same	trade-	
off	(Lee,	Silva,	Li,	&	Slifker,	2011;	Marusyk	&	Polyak,	2010),	and	they	
can	 switch	 between	 migratory	 and	 proliferative	 phenotypes	 (e.g.,	
squamous	cell	carcinoma;	Biddle	et	al.,	2011).	A	theoretical	study	has	
proposed	that	neoplastic	cells,	with	deregulated	metabolism,	may	be	














croenvironment,	with	 the	 potential	 to	 influence	 cellular	metabolism	
(DeBerardinis,	Lum,	Hatzivassiliou,	&	Thompson,	2008).	Because	phe-
notypic	plasticity	in	organisms	has	been	shown	to	be	costly	(DeWitt,	
Sih,	 &	Wilson,	 1998),	 exploring	 the	 costs	 for	malignant	 cells	 of	 ex-
pressing	conditional	 life-	history	strategies	 (e.g.,	 cell	plasticity)	 in	dif-
ferent	environments	is	also	a	promising	direction	for	management	of	
tumorigenesis	(Aktipis	et	al.,	2013).














of	 tumor	 cells	 (Gatenby,	 Brown	 et	al.,	 2009;	 Gatenby,	 Silva	 et	al.,	
2009).	For	example,	a	theoretical	approach	has	confirmed	that	selec-









2.4 | Defenses against multiple aggressors
Decades	of	research	in	applied	ecology	have	illustrated	that	the	evo-
lution	of	defenses	 against	one	natural	 enemy	affects	 the	 individual’s	





anistic	 interactions	 among	 defense	 mechanisms	 (Poitrineau,	 Brown,	




(Gottesman,	 2002)	 and	 immunotherapy	 (Restifo,	 Smyth,	 &	 Snyder,	






3  | LIFE- HISTORY TRADE- OFFS 
AT THE ORGANISM LEVEL
3.1 | Host protective mechanisms
Regarding	 fitness-	reducing	 diseases,	 evolutionary	 theory	 postulates	







Environmental	 factors	 favoring	 cancer	 emergence	 and/or	 progres-
sion	are	potentially	numerous,	their	origins	being	both	anthropogenic	
(e.g.,	radioactivity;	Møller	&	Mousseau,	2015)	and	natural	(e.g.,	natural	
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radiation	levels,	oncogenic	pathogens,	transmissible	cancers,	and	sec-
ondary	compounds	of	plants)	 (Ducasse	et	al.,	2015).	 In	 this	context,	
it	is	predicted	that	traits	allowing	individuals	to	reduce	the	frequency	
or	the	duration	of	exposure	to	those	factors	could	be	favored	by	se-
lection	as	 they	decrease	 cancer	 risk,	 but	will	 likely	 also	entail	 costs	
(Vittecoq	et	al.,	 2015).	Being	 choosy	 to	 avoid	 cancer	 risks	 (with	 re-
spect	to	habitat,	food,	or	partners	with	a	contagious	cancer)	may	entail	




considering	 that	 the	probability	 of	 developing	 an	 aggressive	 cancer	
before	or	during	 the	 reproductive	period	 is	 low	 (Ujvari	 et	al.,	2016)	
and	that	the	perception	of	cancer	risk	may	be	unreliable,	the	benefit	
of	prevention	may	be	offset	by	its	cost.
Even	when	 a	 given	 trait	 (e.g.,	 behavior)	 strongly	 contributes	 to	
protect	 an	 individual	 from	 a	 fitness-	impacting	 cancer,	 it	 may	 not	






health	 (Vittecoq	et	al.,	2015).	For	 instance,	 in	the	case	of	Tasmanian	

















a	 billion	 years	 ago	 (Merlo,	 Pepper,	 Reid,	 &	 Maley,	 2006;	 Nunney,	
2013)),	and	a	major	aspect	of	this	transition	from	unicellular	ancestors	
has	been	the	suppression	of	cell-	level	fitness	to	promote	organism-	
level	 fitness	 (Maynard-	Smith	 &	 Szathmary,	 1997;	 Michod,	 2000).	
Effective	 multicellularity,	 therefore,	 required	 both	 cell	 cooperation	
and	 mechanisms	 for	 eliminating	 conflicts	 arising	 from	 mutations	
that	 can	enhance	 cell-	level	 fitness	 at	 the	 expense	of	 the	 individual	
organism	(Aktipis	et	al.,	2015;	Michod	&	Roze,	2001).	This	situation	






checkpoints,	 telomere	 shortening,	 tissue	 architecture,	 and	 immune	
surveillance	(DeGregori,	2011).

















anisms	 could	be	 to	 select	 protective	 “low-	cost”	mechanisms	 that	 do	
not	 involve	complete	 tumor	elimination.	For	 instance,	auto-	immunity	
is	costly	for	organisms	and	immune	tolerance	occurs	in	response	both	
































in	 other	 essential	 functions	 that	 require	 cell	 proliferation	 (Aktipis	&	
Nesse,	 2013).	 First,	 the	 capacity	 to	 repair	tissues	while	 limiting	un-
controlled	cell	division	represents	a	key	trade-	off	for	any	multicellu-
lar	 organism	 (Aktipis	&	Nesse,	 2013).	 Second,	 cell	 capacities	during	
embryogenesis	 and	 development	 (e.g.,	 “invasion”	 of	 cells	 into	 other	
developing	tissues	during	gastrulation),	which	are	essential	for	repro-




effect	 (Campisi,	 2002,	 2003;	 García-	Cao	 et	al.,	 2002).	 For	 instance,	
mice	carrying	a	p53	mutation	(with	a	phenotypic	effect	analogous	to	
the	upregulation	of	the	gene)	have	a	lower	risk	of	cancer	development,	
but	 their	 life	span	 is	 reduced	and	accompanied	by	early	tissue	atro-
phy	(Donehower,	2002;	Tyner	et	al.,	2002).	However,	a	recent	study	
contradicts	 this	 observation	 in	mice	 and	 has	 demonstrated	 that	 el-





3.1.3 | Alleviating the fitness consequences of cancer
There	are	several	examples	in	the	parasitological	literature	illustrating	
that	hosts,	unable	 to	 resist	 infection	by	other	means	 (e.g.,	 immuno-
logical	 resistance,	 inducible	 defenses,	 or	 long-	distance	 migration),	
present	 adaptive	 and	 flexible	 life-	history	 traits	 that	 partly	 compen-




tumors	 (Ujvari	 et	al.,	 2016).	 From	an	 epidemiological	 point	 of	 view,	
such	responses	could	contribute	to	influence	cancer	risks	through	the	
evolution	of	differential	 cancer	 vulnerabilities.	For	 instance,	BRCA1	
and	BRCA2	mutations	are	inherited	and	predispose	women	to	breast	
and	ovarian	cancer,	but	even	though	carriers	of	these	mutations	have	
reduced	 survival,	 they	also	have	enhanced	 fertility	 (Easton,	Ford,	&	
Bishop,	1995;	Smith,	Hanson,	Mineau,	&	Buys,	2012).	Similarly,	 the	













presence	of	 early-	/late-	life	 trade-	offs	 has	 been	 supported	 and	 sug-
gests	that	individuals	have	to	trade	somatic	maintenance	later	in	life	
for	high	allocation	to	reproduction	early	in	life	because	of	resource-	
limited	 environments	 (Lemaitre	 et	al.,	 2015).	 Costs	 of	 reproduction	
are	therefore	fundamental	to	understand	diseases,	 including	cancer.	
Mechanisms	underlying	the	cost	of	reproduction	are	numerous	from	
hormonal	 regulation	 to	 reduced	 immune	 functioning	 and	 lower	 de-
fenses	against	stress	and	toxicity	(Harshman	&	Zera,	2007).	This	sug-
gests	 that	 selection	 for	 increased	 reproduction	 could	 also	 result	 in	
increased	cancer	susceptibility.
3.2.1 | Sexual competition




contracting	 cancer	when	 they	 compete	with	other	males	 for	mates	
(Hamede,	Bashford,	McCallum,	&	Jones,	2009;	Pearse	&	Swift,	2006).
In	the	context	of	intersexual	selection,	secondary	sexual	traits	(e.g.,	
impressive	 ornaments)	 may	 also	 select	 for	 mechanisms	 that	 enable	




fenses)	 could	also	elevate	cancer	 risk	by	 increasing	accumulation	of	
somatic	mutations	(Boddy	et	al.,	2015).	Knowing	that	success	in	mat-

















Estrogens	 are	 the	 principal	 hormones	 that	 regulate	 the	 female	 re-
productive	 cycle	 and	 have	 been	 particularly	 associated	with	 recep-
tive	behaviors	(Lynch,	Rand,	Ryan,	&	Wilczynski,	2005).	Thus,	females	
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producing	high	levels	of	estrogens	could	be	selected	in	a	context	of	
intrasexual	 competition.	Recent	 studies	have	highlighted	 the	 strong	





suggests	 that	 circulating	 estrogens	 are	 associated	 with	 increased	
postmenopausal	 breast	 cancer	 risk	 (Key,	Appleby,	 Barnes,	 Reeaves,	
&	 Al,	 2002),	 suggesting	 antagonist	 pleiotropy	 even	 if	 mechanisms	
are	not	well	 identified.	Finally,	modification	of	modern	reproductive	
patterns	 has	 been	 associated	with	 an	 increase	 in	 estrogen-	positive	
receptor	(ER+)	breast	cancer	suggesting	that	women	experience	the	
cost	of	a	modernity	mismatch	(Aktipis,	Ellis,	Nishimura,	&	Hiatt,	2014).










with	hierarchical	dominance.	 In	 fact,	 subordinate	 individuals	 show	a	
high	level	of	stress	associated	with	low	levels	of	circulating	testoster-
one,	but	also	with	a	suppressed	immune	system	through	production	




3.3 | Eco- immunological trade- offs
3.3.1 | Infectious disease burdens
Throughout	 evolutionary	 history,	 humans	 have	 been	 exposed	 to	
a	 large	 number	 of	 diverse	 infectious	 agents	 (Wolfe,	 Dunavan,	 &	
Diamond,	 2007).	 In	 wealthy	 countries,	 the	 decreased	 prevalence	
of	 infectious	 diseases,	 in	 particular	 of	 those	 caused	 by	 helminths,	
has	been	paralleled	by	 an	 increased	 incidence	of	 cancers	 (Zacharia,	
Zacharia,	&	Sherman,	2003).	The	helper	T	 lymphocytes	may	have	a	
central	role	for	understanding	the	link	between	infections	and	cancer	









environment	may	 create	 a	mismatch	with	 consequences	 for	 cancer	


















species	 (Samson	&	Nunn,	 2015).	However,	 it	 has	 been	 shown	 that	
sleep	has	a	specific	 role	 in	 the	 formation	of	 immunological	memory	
(Besedovsky,	Lange,	&	Born,	2012).	A	 link	between	cancer	 risk	and	
sleep	has	been	 identified	 in	a	cohort	of	women	with	breast	cancer,	
where	 it	 has	 been	 reported	 that	 women	 who	 routinely	 sleep	 few	






















they	 have	 evolved.	 Such	 knowledge	 could	 lead	 to	 therapies	 that	
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favor	cancer	cells	with	slow	life-	history	strategies	(high	survival,	low	
dispersal,	 and	 slow	 development),	 thereby	 allowing	 for	 long-	term	
cancer	 control	 (Aktipis	 et	al.,	 2013).	 Emerging	 disciplines	 such	 as	
evolutionary	 cell	 biology	 (Lynch	et	al.,	 2014)	 are	promising	 for	un-
derstanding	the	diversity	of	trade-	offs	governing	the	functioning	of	
malignant	 cells,	 their	 consequences	 for	 tumor	 evolution,	 and	 their	
implications	for	novel	therapies.	For	example,	certain	malignant	cells	
may	 behave	 as	 social	 parasitic	 clones	within	 the	 tumor	 benefiting	
from	the	metabolic	investment	made	by	their	neighbors	(e.g.,	stim-
ulating	neo-	angiogenesis	and	the	release	of	growth	factors)	without	
experiencing	costs	 themselves	 (Merlo	et	al.,	2006).	 Interestingly,	 it	
has	been	proposed	that	these	“cheaters”	may	create	a	hypertumor,	
which	could	in	return	damage	or	destroy	the	original	neoplasm	(Nagy	
et	al.,	2007).	However,	 the	existence	of	 trade-	offs	at	 the	cell	 level	
(and	hence	their	potential	use	for	therapies)	implicitly	suggests	that	
resources	are	limited.	At	the	moment,	the	extent	to	which	this	is	the	
case	must	 be	 clarified	because,	 for	 instance,	malignant	 cells	 could	
manipulate	 their	 host	 to	 obtain	 higher	 level	 of	 resources	 (Tissot	
et	al.,	2016).














cancer fitness costs 
Reproduction
Secondary sexual traits, 
sexual hormones
Eco-immunological
Infections, sleep, growth Individual
CANCER SUSCEPTIBILITY
T A B L E  1  Different	scales	of	trade-	offs	and	their	potential	applications	in	public	health:	evidences	from	theoretical,	experimental	and	clinical	
studies
Level Trade- offs
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By	 harnessing	 modern	 technology	 as	 a	 supplement	 to	 natural	









cancer-causing	viruses)	 and	 increased	 sleeping	 time,	which	 can	 re-












and	 infrequent	 exposure	 to	 infectious	 diseases,	 predation,	 and	 vio-
lence.	This	situation	results	in	increased	cancer	incidence	because	the	
largest	 risk	 factor	 for	most	cancers	 is	 simply	aging	 (Frank,	2007).	By	
considering	differences	between	what	natural	selection	acts	on	(repro-
ductive	fitness)	 and	our	 current	 goals	 in	 the	modern	world	 (improv-










To	 conclude,	we	 emphasize	 the	 benefits	 of	 playing	 by	 the	 evo-
lutionary	rules	that	regulate	the	risk	of	cancer,	 rather	than	adopting	
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